{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:53:19Z","timestamp":1769187199713,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T00:00:00Z","timestamp":1329782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10072-012-0976-2","type":"journal-article","created":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T05:58:27Z","timestamp":1329717507000},"page":"217-224","source":"Crossref","is-referenced-by-count":7,"title":["ANT1 is reduced in sporadic inclusion body myositis"],"prefix":"10.1007","volume":"34","author":[{"given":"E.","family":"Barca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Aguennouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mazzeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Portaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,21]]},"reference":[{"key":"976_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08916930600622132","volume":"39","author":"C Briani","year":"2006","unstructured":"Briani C, Doria A, Sarzi-Puttini P, Dalakas MC (2006) Update on idiopathic inflammatory myopathies. Autoimmunity 39:161\u2013170","journal-title":"Autoimmunity"},{"key":"976_CR2","unstructured":"Ballo P, Chiodi L, Cameli M, Malandrini A, Federico A, Mondillo S, Zuppiroli A (2011) Dilated cardiomyopathy and inclusion body myositis. Neurol Sci Sep 16"},{"issue":"5","key":"976_CR3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10072-011-0657-6","volume":"32","author":"C Sancricca","year":"2011","unstructured":"Sancricca C, Mora M, Ricci E, Tonali PA, Mantegazza R, Mirabella M (2011) Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis. Neurol Sci 32(5):841\u2013847","journal-title":"Neurol Sci"},{"key":"976_CR4","doi-asserted-by":"crossref","unstructured":"Murata KY, Kouda K, Tajima F, Kondo T (2011) A dysphagia study in patients with sporadic inclusion body myositis (s-IBM). Neurol Sci","DOI":"10.1007\/s10072-011-0814-y"},{"key":"976_CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.nmd.2007.11.001","volume":"18","author":"M Needham","year":"2008","unstructured":"Needham M, Mastaglia FL (2008) Sporadic inclusion body myositis: a continuing puzzle. Neuromuscul Disord 18:6\u201316","journal-title":"Neuromuscul Disord"},{"key":"976_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9440(10)63089-1","volume":"164","author":"G Vattemi","year":"2004","unstructured":"Vattemi G, Engel WK, McFerrin J, Askanas V (2004) Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am J Pathol 164:1\u20137","journal-title":"Am J Pathol"},{"key":"976_CR7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00401-007-0281-y","volume":"114","author":"S Wojcik","year":"2007","unstructured":"Wojcik S, Engel WK, Yan R, McFerrin J, Askanas V (2007) NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A\u03b2PP-overexpressing cultured human muscle fibers. Acta Neuropathol 114:517\u2013526","journal-title":"Acta Neuropathol"},{"key":"976_CR8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410390615","volume":"39","author":"FM Santorelli","year":"1996","unstructured":"Santorelli FM, Sciacco M, Tanji K et al (1996) Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients. Ann Neurol 39:789\u2013795","journal-title":"Ann Neurol"},{"key":"976_CR9","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1212\/01.wnl.0000192127.63013.8d","volume":"66","author":"A Oldfors","year":"2006","unstructured":"Oldfors A, Moslemi AR, Jonasson L, Ohlsson M, Kollberg G, Lindberg C (2006) Mitochondrial abnormalities in inclusion-body myositis. Neurology 66:S49\u2013S55","journal-title":"Neurology"},{"key":"976_CR10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.expneurol.2006.12.014","volume":"204","author":"A Nogalska","year":"2007","unstructured":"Nogalska A, Wojcik S, Engel WK, McFerrin J, Askanas V (2007) Endoplasmic reticulum stress induces myostatin precursor protein and NF-kappaB in cultured human muscle fibers: relevance to inclusion body myositis. Exp Neurol 204:610\u2013618","journal-title":"Exp Neurol"},{"key":"976_CR11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0014-4886(02)00025-0","volume":"179","author":"G Vattemi","year":"2003","unstructured":"Vattemi G, Engel WK, McFerrin J, Pastorino L, Buxbaum JD, Askanas V (2003) BACE1 and BACE2 in pathologic and normal human muscle. Exp Neurol 179:150\u2013158","journal-title":"Exp Neurol"},{"key":"976_CR12","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1212\/01.wnl.0000192128.13875.1e","volume":"66","author":"V Askanas","year":"2006","unstructured":"Askanas V, Engel WK (2006) Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition. Neurology 66:S39\u2013S48","journal-title":"Neurology"},{"key":"976_CR13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ana.410230511","volume":"23","author":"K Arahata","year":"1988","unstructured":"Arahata K, Engel A (1988) Monoclonal antibody analysis of mononuclear cells in myopathies: identification and quantification of T8+ cytotoxic and T8+ suppressor cells. Ann Neurol 23:493\u2013499","journal-title":"Ann Neurol"},{"key":"976_CR14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00005072-199612000-00003","volume":"55","author":"C Schneider","year":"1996","unstructured":"Schneider C, Gold R, Dalakas MC et al (1996) MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis. J Neuropathol Exp Neurol 55:1205\u20131209","journal-title":"J Neuropathol Exp Neurol"},{"key":"976_CR15","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1101\/gad.909001","volume":"15","author":"N Silverman","year":"2001","unstructured":"Silverman N, Maniatis T (2001) NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev 15:2321\u20132342","journal-title":"Genes Dev"},{"key":"976_CR16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18:621\u2013663","journal-title":"Annu Rev Immunol"},{"key":"976_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1172\/JCI11837","volume":"107","author":"G Zhang","year":"2001","unstructured":"Zhang G, Ghosh S (2001) Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 107:13\u201319","journal-title":"J Clin Invest"},{"key":"976_CR18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725\u2013734","journal-title":"Nat Rev Immunol"},{"key":"976_CR19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","volume":"2","author":"M Karin","year":"2002","unstructured":"Karin M, Cao Y, Greten FR, Li ZW (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301\u2013310","journal-title":"Nat Rev Cancer"},{"key":"976_CR20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/mus.10172","volume":"26","author":"G Fagiolari","year":"2002","unstructured":"Fagiolari G, Sciacco M, Chiveri L et al (2002) Lack of apoptosis in patients with progressive external ophthalmoplegia and mutated adenine nucleotide translocator-1 gene. Muscle Nerve 26:265\u2013269","journal-title":"Muscle Nerve"},{"issue":"9","key":"976_CR21","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1073\/pnas.96.9.4820","volume":"96","author":"LA Esposito","year":"1999","unstructured":"Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC (1999) Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 96(9):4820\u20134825","journal-title":"Proc Natl Acad Sci USA"},{"key":"976_CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1097-2765(00)80307-X","volume":"3","author":"MG Vander Heiden","year":"1999","unstructured":"Vander Heiden MG, Chandel NS, Schumacker PT, Thompson CB (1999) Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP\/ADP exchange. Mol Cell 3:159\u2013167","journal-title":"Mol Cell"},{"key":"976_CR23","doi-asserted-by":"crossref","first-page":"38415","DOI":"10.1074\/jbc.M404928200","volume":"279","author":"M Zamora","year":"2004","unstructured":"Zamora M, Mero\u00f1o C, Vi\u00f1as O, Mampel T (2004) Recruitment of NF-kappaB into mitochondria is involved in adenine nucleotide translocase 1 (ANT1)-induced apoptosis. J Biol Chem 279:38415\u201338423","journal-title":"J Biol Chem"},{"key":"976_CR24","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1212\/WNL.43.6.1265-a","volume":"43","author":"V Askanas","year":"1993","unstructured":"Askanas V, Engel WK, Alvarez RB (1993) Enhanced detection of congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer\u2019s disease using fluorescence technique. Neurology 43:1265\u20131267","journal-title":"Neurology"},{"issue":"6","key":"976_CR25","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1212\/WNL.51.6.1525-a","volume":"51","author":"M Zeviani","year":"1998","unstructured":"Zeviani M, Moraes CT, DiMauro S, Nakase H, Bonilla E, Schon EA, Rowland LP (1998) Deletions of mitochondrial DNA in Kearns\u2013Sayre syndrome. Neurology 51(6):1525\u20131532","journal-title":"Neurology"},{"key":"976_CR26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.410390318","volume":"39","author":"V Askanas","year":"1996","unstructured":"Askanas V, Alvarez RB, Mirabella M, Engel WK (1996) Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis. Ann Neurol 39:389\u2013391","journal-title":"Ann Neurol"},{"key":"976_CR27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0404.2006.00724.x","volume":"115","author":"V Macaione","year":"2007","unstructured":"Macaione V, Aguennouz M, Rodolico C et al (2007) RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy. Acta Neurol Scand 115:115\u2013121","journal-title":"Acta Neurol Scand"},{"key":"976_CR28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/01.WNL.0000049913.27181.51","volume":"60","author":"MC Monici","year":"2003","unstructured":"Monici MC, Aguennouz M, Mazzeo A, Messina C, Vita G (2003) Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 60:993\u2013997","journal-title":"Neurology"},{"key":"976_CR29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3940(98)00657-0","volume":"254","author":"CC Yang","year":"1998","unstructured":"Yang CC, Askanas V, Engel WK, Alvarez RB (1998) Immunolocalization of transcription factor NF-kappaB in inclusion-body myositis muscle and at normal human neuromuscular junctions. Neurosci Lett 254:77\u201380","journal-title":"Neurosci Lett"},{"key":"976_CR30","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/cbic.200400144","volume":"5","author":"ML Schmitz","year":"2004","unstructured":"Schmitz ML, Mattioli I, Buss H, Kracht M (2004) NF-kappaB: a multifaceted transcription factor regulated at several levels. Chembiochem 5:1348\u20131358","journal-title":"Chembiochem"},{"key":"976_CR31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jemt.20186","volume":"67","author":"V Askanas","year":"2005","unstructured":"Askanas V, Engel WK (2005) Molecular pathology and pathogenesis of inclusion-body myositis. Microsc Res Tech 67:114\u2013120","journal-title":"Microsc Res Tech"},{"key":"976_CR32","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1038\/sj.onc.1203238","volume":"18","author":"M Barkett","year":"1999","unstructured":"Barkett M, Gilmore TD (1999) Control of apoptosis by Rel\/NF-kappaB transcription factors. Oncogene 18:6910\u20136924","journal-title":"Oncogene"},{"key":"976_CR33","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1038\/sj.onc.1205489","volume":"21","author":"S Delhalle","year":"2002","unstructured":"Delhalle S, Deregowski V, Benoit V, Merville MP, Bours V (2002) NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis. Oncogene 21:3917\u20133924","journal-title":"Oncogene"},{"key":"976_CR34","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/brain\/121.11.2119","volume":"121","author":"R Lodi","year":"1998","unstructured":"Lodi R, Taylor DJ, Tabrizi SJ et al (1998) Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy. Brain 121:2119\u20132126","journal-title":"Brain"},{"key":"976_CR35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-4157(95)00003-A","volume":"1241","author":"M Zoratti","year":"1995","unstructured":"Zoratti M, Szab\u00f2 I (1995) The mitochondrial permeability transition. Biochim Biophys Acta 1241:139\u2013176","journal-title":"Biochim Biophys Acta"},{"key":"976_CR36","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bbabio.2008.03.009","volume":"1777","author":"AW Leung","year":"2008","unstructured":"Leung AW, Halestrap AP (2008) Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim Biophys Acta 1777:946\u2013952","journal-title":"Biochim Biophys Acta"},{"key":"976_CR37","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/brain\/120.6.929","volume":"120","author":"L Behrens","year":"1997","unstructured":"Behrens L, Bender A, Johnson MA, Hohlfeld R (1997) Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells. Brain 120:929\u2013938","journal-title":"Brain"},{"key":"976_CR38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1034\/j.1600-0404.2002.01198.x","volume":"105","author":"IM Fyhr","year":"2002","unstructured":"Fyhr IM, Lindberg C, Oldfors A (2002) Expression of Bcl-2 in inclusion body myositis. Acta Neurol Scand 105:403\u2013407","journal-title":"Acta Neurol Scand"},{"key":"976_CR39","first-page":"541","volume":"63","author":"AS Belzacq","year":"2003","unstructured":"Belzacq AS, Vieira HL, Verrier F et al (2003) Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res 63:541\u2013546","journal-title":"Cancer Res"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-012-0976-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-012-0976-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-012-0976-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T20:18:32Z","timestamp":1561321112000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-012-0976-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,21]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["976"],"URL":"https:\/\/doi.org\/10.1007\/s10072-012-0976-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,21]]}}}